SCHEDULE: FMR LLC Discloses 5.4% Stake in Artivion Inc.
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have disclosed a beneficial ownership of 5.4% of Artivion Inc.'s common stock as of June 30, 2025.
Summary
- FMR LLC and Abigail P. Johnson reported beneficial ownership of 2,288,030.10 shares of Artivion Inc. common stock.
- This represents 5.4% of the total outstanding common stock of Artivion Inc.
- The ownership position is as of June 30, 2025.
- FMR LLC holds sole voting power over 2,285,792.00 shares and sole dispositive power over 2,288,030.10 shares.
- Abigail P. Johnson holds sole dispositive power over 2,288,030.10 shares.
- This is an Amendment No. 1 to a Schedule 13G, filed under Rule 13d-1(b).
- FMR LLC is classified as a parent holding company, with subsidiaries including Fidelity Institutional Asset Management Trust Company and Fidelity Management & Research Company LLC.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Artivion Inc.
Sentiment
Score: 7
Explanation: The disclosure of a significant 5.4% stake by a major institutional investor like FMR LLC in Artivion Inc. is generally viewed as a positive signal of confidence in the company's long-term prospects, even though the filing itself is purely informational and passive.
Positives
- A major institutional investor, FMR LLC, holds a significant 5.4% stake in Artivion Inc., indicating confidence in the company.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control, suggesting a passive investment.
Future Outlook
NA
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ยงยง 240.14a-11."
Industry Context
This filing is a standard disclosure of institutional ownership and does not provide specific insights into broader industry trends or competitive dynamics within the medical device or healthcare sector. It primarily reflects an investment decision by FMR LLC in Artivion Inc.
Stakeholder Impact
- Shareholders: The disclosure of a significant stake by a reputable institutional investor like FMR LLC may instill greater confidence among existing and potential shareholders, potentially leading to increased investor interest.
Key Dates
| Date | Description |
|---|---|
| 2023-05-23 | Effective date of Power of Attorney for Richard Bourgelas to sign on behalf of FMR LLC and Abigail P. Johnson. |
| 2023-08-08 | Date of previous Schedule 13G filing by FMR LLC, referenced for Power of Attorney accession number. |
| 2025-06-30 | Date of event which requires filing of this statement; the ownership position is reported as of this date. |
| 2025-08-05 | Date of filing of this Schedule 13G and the joint filing agreement. |
Recommendation
holdThis filing is a disclosure of beneficial ownership by a major institutional investor, FMR LLC, in Artivion Inc. It indicates a significant, passive stake (5.4%) but does not provide any new operational, financial, or strategic information about Artivion Inc. that would warrant a change in investment recommendation. Investors should consider this as a data point on institutional interest rather than a direct signal for buying or selling, and base their decisions on Artivion's fundamental performance and market conditions.
Keywords
Artivion Inc, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investment, SEC Filing, Healthcare, Medical Devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.